Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study

J Tiihonen; O P Ryynänen; J Kauhanen; H P Hakola; M Salaspuro

doi:10.1055/s-2007-979538

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study

Pharmacopsychiatry. 1996 Jan;29(1):27-9. doi: 10.1055/s-2007-979538.

Authors

J Tiihonen¹, O P Ryynänen, J Kauhanen, H P Hakola, M Salaspuro

Affiliation

¹ Department of Forensic Psychiatry, University of Kuopio, Finland.

PMID: 8852531
DOI: 10.1055/s-2007-979538

Abstract

The effect of citalopram and placebo in the treatment of alcoholism was studied in a sample of 62 patients with a follow-up period of four months. The results imply that the new 5-HT re-uptake inhibitor citalopram is significantly more effective than placebo in the treatment of alcoholism. The present study indicates that even severe alcoholism may be treated effectively with a generally available psychopharmacological agent.

Publication types

Clinical Trial
Comparative Study
Controlled Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Alcoholism / drug therapy*
Alcoholism / prevention & control
Antidepressive Agents / therapeutic use*
Citalopram / therapeutic use*
Double-Blind Method
Finland
Humans
Male
Middle Aged
Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

Antidepressive Agents
Serotonin Uptake Inhibitors
Citalopram